Business context and reporting period
Smith & Wesson Brands, Inc. designs and manufactures firearms and related products, including handguns, long guns, suppressors and handcuffs, and provides manufacturing services. Its principal brands include Smith & Wesson, M&P and Gemtech.
This is the company’s Form 10-K for the fiscal year ended April 30, 2023—not a standalone 2022 fourth-quarter filing. Unless stated otherwise, figures below are for continuing operations.
Financial performance and liquidity
| Metric | FY2023 | FY2022 |
|---|---|---|
| Net sales | $479.2 million | $864.1 million |
| Gross profit / margin | $154.5 million / 32.2% | $374.6 million / 43.3% |
| Operating income / margin | $48.4 million / 10.1% | $251.7 million / 29.1% |
| Net income | $36.9 million | $194.5 million |
| Diluted earnings per share | $0.80 | $4.08 |
| Cash from operating activities | $16.7 million | $137.8 million |
| Capital expenditures | $89.6 million | $24.0 million |
| Cash and cash equivalents at year-end | $53.6 million | $120.7 million |
At April 30, 2023, current assets were $291.9 million and current liabilities were $87.2 million. Inventory was $177.1 million, up from $136.7 million. The company reported $25.0 million borrowed on its $100 million revolving credit line (6.62% interest at year-end) and $38.4 million in total finance lease liabilities, primarily related to its Missouri distribution center. It was in compliance with debt covenants. Management said available capital and credit facilities should fund operations for the next 12 months.
Cash declined $67.2 million during the year. Operating cash flow fell sharply, while investing cash use increased with relocation-related construction. The company paid $18.3 million in dividends and made no share repurchases in FY2023. Operating cash flow less capital expenditures was approximately negative $72.8 million.
Material changes versus the prior comparable period
- Sales fell 44.5%; handgun sales declined 42.2% and long-gun sales declined 60.8%. Unit shipments fell 47.8% for handguns and 59.2% for long guns.
- Management attributed the decline mainly to demand normalizing after unusually high pandemic-era demand and distributors reducing elevated inventories. It said company shipments underperformed broader demand indicators partly because channel inventory had been replenished heavily in FY2022.
- Gross margin contracted 11.1 percentage points. Lower volume, inflation in materials and labor, weaker fixed-cost absorption and relocation expenses were principal pressures.
- Operating income declined 80.8%, net income declined 81.0%, and operating cash flow declined 87.9%.
- Operating expenses decreased 13.7%, but rose to 22.1% of sales from 14.2% as revenue contracted.
Outlook, commentary, risks and unusual items
- Relocation: The company is building a new facility in Maryville, Tennessee, and expects total construction and equipment capital expenditures of approximately $160–$170 million through FY2024. Through April 30, 2023, it had incurred $93.5 million in relocation capital expenditures and $18.5 million in other restructuring charges. For FY2024, it expected $70–$75 million of relocation-related capital expenditures, including $50–$55 million for facility construction, plus $20–$25 million of other capital expenditures. Some relocation activity is expected to extend into FY2025.
- Operations and demand: Management expects inventory to remain elevated during the transition and expects inflation to have a greater impact in FY2024. It described overall firearm demand as healthy but normalized. It plans to continue introducing products in FY2024.
- Relocation and workforce risks: Completion, cost, hiring and employee retention could differ from expectations and disrupt production or distribution. The company also cited challenging labor markets and management time devoted to the move.
- Industry and regulatory risks: Demand is sensitive to economic conditions, consumer spending, political and social events, firearm legislation and distributor inventory levels. The company also faces risks from supplier costs and availability, competition, product quality and liability claims, insurance availability, export controls, cybersecurity, and potential changes in environmental regulation.
- Litigation and contingencies: The company disclosed multiple product-liability and other lawsuits and investigations. It said it could not estimate a range of reasonably possible additional losses for material adverse judgments. Product-litigation reserves of $4.3 million consisted entirely of expected legal defense costs. It reported no environmental reserve despite ongoing Springfield-area remediation and potentially responsible-party notices at two sites.
- Other notable items: FY2023 restructuring charges were $8.3 million. A $100,000 deposit-related expense is not indicated; the filing text does not provide a clear value for any such item. The company reported an estimated $40,000 remaining accrual related to recalls, safety alerts and consumer advisories, alongside ordinary warranty accruals. Auditors issued unqualified opinions on the financial statements and internal control over financial reporting; management also reported effective controls.
Important facts for investors to verify
- Whether distributor inventories normalize and sales recover without renewed discounting or further margin pressure.
- Maryville project spending, construction timing, relocation charges, workforce transition and operational continuity.
- Inventory valuation and obsolescence exposure, particularly given the year-over-year increase and management’s expectation of elevated inventory.
- Cash generation and funding needs relative to relocation expenditures, dividends, the revolving credit line and lease obligations.
- Developments in product-liability litigation, insurance coverage and environmental matters; several potential loss amounts are not estimable in the filing.
- FY2024 cost inflation, demand conditions, regulatory changes and execution of new product launches.